Ocular Therapeutix™ Reports Second Quarter 2021 Financial Results and Business Update
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Nasdaq futures lead Wall St gains as oil retreat eases inflation worries
- Oil prices set for weekly fall on easing fears over Saudi supply disruption
- The Fed is hiking. Why isn't UBS worried about stocks?
- Wall Street on Fed rate hike: 'As hawkish as it gets'
- RBC bullish on Kraft Heinz, sees return to growth in 2027
Ocular Therapeutix (OCUL) Misses Q2 EPS by 4c
August 9, 2021 4:54 PM EDTOcular Therapeutix (NASDAQ: OCUL) reported Q2 EPS of ($0.25), $0.04 worse than the analyst estimate of ($0.21). Revenue for the quarter came in at $11.7 million versus the consensus estimate of $11.6 million.
For earnings history and earnings-related data on Ocular Therapeutix (OCUL) click here.
... More